Munafo A, Hyneck M L, Benet L Z
Department of Pharmacy, University of California, San Francisco 94143-0446.
Pharmacology. 1993 Nov;47(5):309-17. doi: 10.1159/000139112.
In a previous study, the disposition and irreversible plasma protein binding of tolmetin have been described in young volunteers. Significant levels of tolmetin glucuronide and its isomer(s) were found in plasma, and irreversible binding was shown to occur in all subjects. In the present study, the pharmacokinetics and irreversible binding in 5 elderly volunteers are investigated after a single dose (400 mg) of tolmetin. No difference of physiological importance has been found, unless weight correction is employed, when compared with the young subjects. Very strong correlations were present between the level of binding and exposure to the glucuronide or its isomer. An elderly patient currently treated with tolmetin (400 mg b.i.d.) also participated in the study. The results show an accumulation of the irreversible binding to levels 4-17 times higher than after a single dose. Nevertheless, neither toxic nor allergic reactions have been observed in this patient.
在先前的一项研究中,已对托美丁在年轻志愿者体内的处置和不可逆血浆蛋白结合情况进行了描述。在血浆中发现了显著水平的托美丁葡糖醛酸苷及其异构体,并且在所有受试者中均显示发生了不可逆结合。在本研究中,对5名老年志愿者单次服用(剂量为400 mg)托美丁后的药代动力学和不可逆结合情况进行了研究。与年轻受试者相比,除非进行体重校正,否则未发现具有生理重要性的差异。结合水平与葡糖醛酸苷或其异构体的暴露量之间存在非常强的相关性。一名目前正在接受托美丁治疗(每日两次,每次400 mg)的老年患者也参与了该研究。结果显示不可逆结合出现蓄积,其水平比单次给药后高4至17倍。然而,在该患者中未观察到毒性反应或过敏反应。